Theratechnologies (THTX) SEC Filings, Jul 3-29, 2025

Theratechnologies Inc. filings document foreign-issuer current reports, shareholder materials and corporate-status disclosures for a commercial-stage biopharmaceutical company. The record includes Form 6-K reports furnished with press releases, a material change report, special meeting materials, a management proxy circular, proxy forms, voting instructions and a letter of transmittal.

The filings also document the company’s common shares, capital-structure matters, governance and shareholder voting processes, product and business updates, and a Form 25 notification of removal from Nasdaq listing and registration under Section 12(b) of the Exchange Act following the completed acquisition transaction.